Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

1.135

-0.025 (-2.16%)

Feb 23, 2026, 9:34 AM EST - Market open

Citius Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 23, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Market Capitalization	100	170	99	96	-
Market Cap Growth	11.13%	71.05%	2.93%	-	-
Enterprise Value	99	173	-	-	-
Last Close Price	1.16	2.03	1.39	10.77	-
PB Ratio	1.68	3.78	2.15	3.77	-
P/TBV Ratio	1.75	3.78	2.15	3.77	-
P/OCF Ratio	-	-	784.41	-	-
Debt / Equity Ratio	0.07	0.09	0.08	-	-
Net Debt / Equity Ratio	-0.06	0.00	0.08	-	-
Quick Ratio	0.25	0.08	0	-	-
Current Ratio	0.83	0.56	0.34	0.37	0.46
Return on Equity (ROE)	-47.41%	-54.42%	-59.01%	-41.09%	-
Return on Assets (ROA)	-13.96%	-15.87%	-19.47%	-16.76%	-
Return on Capital Employed (ROCE)	-34.30%	-45.70%	-39.80%	-45.40%	-26.40%
Earnings Yield	-23.08%	-14.61%	-21.34%	-13.19%	-
Buyback Yield / Dilution	-11.84%	-7.66%	-0.82%	-100.00%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q